Supernus Pharmaceuticals
SUPN
SUPN
57 hedge funds and large institutions have $187M invested in Supernus Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 53 → 57 (+4)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
57
Holding in Top 10
3
Calls
$15.1M
Puts
$10M
Top Buyers
| 1 | +$1.16M | |
| 2 | +$1.09M | |
| 3 | +$1.05M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$784K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$733K |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$1.72M | |
| 3 | -$695K | |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$547K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$514K |